ALNYLAM PHARMACEUTICALS, INC. Financing Cash Flow 2008-2025 | ALNY
Beta
What is financing cash flow?
Financing cash flow represents cash from or used in financing activities, including borrowing, repaying debt, issuing or repurchasing stock, and paying dividends.
What is ALNYLAM PHARMACEUTICALS, INC.'s current financing cash flow?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual financing cash flow for 2025 was $-305.2M, a 203.75% decline from 2024. ALNYLAM PHARMACEUTICALS, INC. financing cash flow for the quarter ending December 31, 2025 was $45.3M.
What was ALNYLAM PHARMACEUTICALS, INC.'s financing cash flow in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual financing cash flow for 2024 was $294.2M, a 70.89% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s financing cash flow in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual financing cash flow for 2023 was $172.1M, a 59.57% decline from 2022.
Financing Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$995.0M
→
FY2025
$-305.2M
080910111213141516171819202122232425
5 years selected
Financing Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-305.2M | -203.8% | 10-K |
| FY2024 | $294.2M | +70.9% | 10-K |
| FY2023 | $172.1M | -59.6% | 10-K |
| FY2022 | $425.8M | -65.9% | 10-K |
| FY2021 | $1.25B | +25.3% | 10-K |
| FY2020 | $995.0M | +20.9% | 10-K |
| FY2019 | $823.2M | +1157.3% | 10-K |
| FY2018 | $65.5M | -94.2% | 10-K |
| FY2017 | $1.12B | +532.6% | 10-K |
| FY2016 | $177.8M | -71.1% | 10-K |
| FY2015 | $616.2M | -16.3% | 10-K |
| FY2014 | $736.5M | +266.5% | 10-K |
| FY2013 | $200.9M | +115.1% | 10-K |
| FY2012 | $93.4M | +12557.5% | 10-K |
| FY2011 | $738,000 | -79.9% | 10-K |
| FY2010 | $3.7M | +4.4% | 10-K |
| FY2009 | $3.5M | +11.2% | 10-K |
| FY2008 | $3.2M | - | 10-K |
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →